J&J taps Mammen for R&D job; Hait to lead external innovation

Johnson & Johnson (NYSE:JNJ) hired Mathai Mammen to succeed William Hait as global head of R&D. Hait will take on a newly created role as global head of external innovation. Mammen is joining J&J from the Merck Research Labs division of Merck & Co. Inc. (NYSE:MRK), where he is SVP of cardiovascular and metabolic diseases, immunology and oncology.

Hait will oversee the company's Johnson & Johnson Innovation unit, including the company's Innovation Centers, JLABS and JJDC, as well as the company's cross-sector lung cancer and obesity initiatives and its "World Without Disease" innovation strategy...